Plateforme Level Extreme
Abonnement
Profil corporatif
Produits & Services
Support
Légal
English
Another example of modern 'MBA-style' ethics???
Message
De
14/03/2006 14:18:29
 
 
À
14/03/2006 14:09:27
Information générale
Forum:
Science & Medicine
Catégorie:
Expériences
Divers
Thread ID:
01103811
Message ID:
01104329
Vues:
22
>Has this substance been approved by the FDA? According to Jim's post (and I'll grant that I didn't do the research to verify the post), this is not the case. It is in a trial period.
>
>Therefore.....
>
>"There is a substance called PolyHeme that is scientifically proven to increase the chances of surviving a life threatening loss of blood."
>
>is inaccurate when you say "scientifically proven."

Your argument is only true if "scientifically proven" can only mean "approved by the FDA".

That's ridiculous.

This is from the FAQ posted elsewhere in the thread:

Is PolyHeme® safe?

In clinical trials to date, PolyHeme® has demonstrated no “clinically relevant” adverse effects. That is, they didn’t impact the patient’s safety or recovery.

Past studies have shown that PolyHeme® carries as much oxygen as blood, has not caused organ damage, keeps people alive who have lost all of their own blood, and can be infused up to two times a person’s entire blood volume.


Has PolyHeme® been tested on humans before?

There have been 5 human clinical trials of PolyHeme®.


How many patients have been treated with PolyHeme®?

Over 300 patients have been treated, including patients in a hospital-based trauma trial.


What happened to them?

In the Phase II hospital trauma trial, PolyHeme® significantly increased survival compared with historical controls.



Clearly the scientific evidence is that PolyHeme can save lives.


> I don't want to be the subject of an experiment without my consent.

So you'd rather die at the scene of a horrific accident than take on PolyHeme?

That's fine with me.


Did you get your bracelet yet?
Précédent
Suivant
Répondre
Fil
Voir

Click here to load this message in the networking platform